Evans syndrome during pembrolizumab therapy for upper urinary tract cancer.

IJU Case Rep · 2023 · PMC10475338 · PMID 37667757

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

However, a clear trend regarding which disease manifested first was not established. 4 As this patient experienced anemia; jaundice, with elevated reticulocyte, indirect bilirubin, and LDH; AIHA; and ITP with thrombocytopenia, drug‐induced secondary ES was strongly suggested.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.